Stryker Corporation SYK
272.36
2.61
0.97%
as of 25 Sep
- Market cap
- $103.9B
- P/E
- 28.0×
Follow SYK
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Stryker Corporation (SYK) P/B ratio
As of 25 September 2026, Stryker Corporation (SYK) trades at a P/B ratio of 4.4×. Over the past ten years it has ranged from 3.7× (March 2020) to 7.6× (September 2021); the current reading is higher than 7% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.5×.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 6.0× | (9.88%) |
| FY2024 | 6.6× | 9.93% |
| FY2023 | 6.0× | 8.00% |
| FY2022 | 5.6× | (17.37%) |
| FY2021 | 6.8× | (3.64%) |
| FY2020 | 7.0× | 14.71% |
| FY2019 | 6.1× | 22.64% |
| FY2018 | 5.0× | (15.52%) |
| FY2017 | 5.9× | 26.48% |
| FY2016 | 4.7× | 13.76% |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 5.0× | (8.07%) |
| Mar 2026 | 5.5× | (8.62%) |
| Dec 2025 | 6.0× | (7.67%) |
| Sep 2025 | 6.5× | (9.06%) |
| 42 more quarters | Free account |
Against its own ten years
Low 3.7×
High 7.6×
Ten-year median
6.1×
Current reading's percentile
7
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| PHG Koninklijke Philips N.V. compare | 1.8× |
| MDT Medtronic PLC compare | 2.2× |
| BSX Boston Scientific Corporation compare | 2.6× |
| GEHC GE HealthCare Technologies Inc. compare | 2.7× |
| STE STERIS plc compare | 2.8× |
| ABT Abbott Laboratories compare | 3.4× |
| SYK Stryker Corporation | 4.4× |
| EW Edwards Lifesciences Corporation compare | 4.6× |
| DXCM DexCom, Inc. compare | 12.6× |
| Medical Devices industry median | 2.5× |
| Healthcare sector median | 2.5× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on SYK
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement